The hydrogen sulfide donor, GYY4137, exhibits anti‐atherosclerotic activity in high fat fed apolipoprotein E−/− mice
Scavenger Receptor
Monocyte
DOI:
10.1111/bph.12246
Publication Date:
2013-05-28T11:27:11Z
AUTHORS (17)
ABSTRACT
Atherosclerosis is associated with reduced vascular hydrogen sulfide (H2 S) biosynthesis. GYY4137 a novel slow-releasing H2 S compound that may effectively mimic the time course of release in vivo. However, it not known whether affects atherosclerosis.RAW 264.7 cells and human blood monocyte-derived macrophages were incubated oxidized low density lipoprotein (ox-LDL) with/without GYY4137. ApoE(-/-) mice fed high-fat diet for 4 weeks administered 30 days. Lipid atherosclerotic lesions measured by oil red O staining. Endothelium-dependent relaxation was assessed response to acetylcholine. Superoxide production detected dihydroethidium Expression mRNA protein evaluated quantitative real-time PCR Western blot.GYY4137 inhibited ox-LDL-induced foam cell formation cholesterol esterification cultured cells. decreased expression lectin-like ox-LDL receptor-1, iNOS, phosphorylated IκBα, NF-κB, ICAM-1, VCAM-1 chemokines, including CXCL2, CXCR4, CXCL10 CCL17, but increased scavenger CD36, ox-LDL-treated RAW In vivo, aortic plaque partially restored endothelium-dependent apoE(-/-) mice. TNF-α IL-6 as well superoxide (O2 (-) ) generation aorta. addition, eNOS phosphorylation PI3K, enhanced Akt Ser(473) down-regulated LOX-1.GYY4137 inhibits lipid accumulation induced inflammation oxidative stress, improved endothelial function
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (46)
CITATIONS (151)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....